Latest

immune system

·September 27, 2022·4 min read

New Model of Alzheimer’s as an Autoimmune Disease

Researchers propose a new model for Alzheimer's disease (AD2) that considers the neurodegenerative disease as an autoimmune disease that attacks the brain. Considering Alzheimer's as an autoimmune disorder could spark a new line of therapies to treat the disease.

This shows someone doing a finger prick test

Featured Neurology Neuroscience

·September 24, 2022·4 min read

COVID-19 Associated With Increase in New Diagnoses of Type 1 Diabetes in Youth, by as Much as 72%

Children who contracted COVID-19 are at increased risk of being diagnosed with Type 1 diabetes. Researchers found a 72% increase in new Type 1 diabetes cases in those under 18 who contracted COVID-19.

Featured Neurology Neuroscience

·September 21, 2022·4 min read

A Consistent Lack of Sleep Negatively Impacts Immune Stem Cells, Increasing Risk of Inflammatory Disorders and Heart Disease

Sleep deprivation alters the structure of DNA inside immune cells and increases the number of immune cells, which causes them to overreact and spark inflammation. The study found catching up on sleep does not reverse this effect.

Featured Neurology Neuroscience Open Neuroscience Articles

·September 20, 2022·4 min read

Understanding the Connection Between the Immune System and Regeneration

Using zebrafish, researchers investigated the timing and genetic programming of macrophages that help repair and regenerate the sensory organs within the fish. The findings could help pave the way for regenerative treatments for spinal cord injuries, hearing loss, and heart disorders in humans.

Featured Neuroscience

·August 30, 2022·2 min read

Surrounded by Sick Coworkers? Your Body Is Preparing for Battle

Our brains obtain information from sick people, eliciting changes in our physiology and immune response. Observing images of ill people triggers activation of the immune system.

Featured Neuroscience

·August 21, 2022·4 min read

Lupus Pill Shows Promise in Mice; Clinical Trial Underway

Afimetoran, a newly developed pill to treat lupus, not only prevents lupus-like symptoms in mice, it also reverses signs of organ damage caused by the disease and prevents death. The medication is now undergoing phase 2 clinical trials to assess its effectiveness in lupus patients.

Featured Neurology Neuroscience

·August 4, 2022·6 min read

How Microglia Contribute to Alzheimer’s Disease

Microglia that express the Alzheimer's associated APOE4 genetic variant are unable to effectively metabolize lipids. This causes lipids to build up, promoting inflammation and preventing effective neurotransmission.

Featured Genetics Neurology Neuroscience

·July 5, 2022·4 min read

Study Links ALS to Immune and Central Nervous Systems

Based on new findings, researchers say bone marrow transplants may be an effective treatment for ALS.

Featured Genetics Neuroscience

·July 2, 2022·3 min read

Important Factors for Regulating the Body’s Immune Response

Researchers identified differences in isoforms that control Treg cells and how that affects the body's immune system response.

Featured Neuroscience Psychology

·June 29, 2022·5 min read

Research Sheds Light on Mechanism by Which Long-Term Anti-Anxiety Drug Use Affects the Brain

Study reveals a possible mechanism by which anxiolytic medications act on the brain, leading to cognitive impairment.

Featured Neurology Neuroscience

·June 26, 2022·4 min read

Flu Vaccination Linked to 40% Reduced Risk of Alzheimer’s Disease

Older adults who received at least one flu vaccination were 40% less likely to develop Alzheimer's disease over the course of a four year follow up than their peers who did not receive a vaccine.